M&S Set to Rejoin FTSE 100 After Four-Year Hiatus
M&S Set to Rejoin FTSE 100 After Four-Year Hiatus
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that Chris Lea, Group Finance Director of the Company, will be stepping down as
After Germany’s cabinet greenlit new legislation permitting the recreational use and cultivation of cannabis, predictions have emerged that the rest of Europe, including the UK, may follow suit.
A total of £7 million in fines have been imposed on over 200 companies for violations affecting 63,000 employees, including non-payment of minimum wages.
This week is filled with busy results announcements for London-listed companies, with big names like Barclays and NatWest, AstraZeneca and GSK, Unilever and Reckitt Benckiser, as well as US tech
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, provides a trading update which reflects lower than expected revenue,
Maiden US Laboratory FoodPrint® installation,
Test shows high diagnostic accuracy (specificity and sensitivity)
Change of preliminary results date and investor presentation and update to CD4 sale
Completion of Sale of the CD4 Business
Omega Diagnostics Group PLC, (AIM: ODX). announced that it has selected a preferred bidder for its CD4 business after having made an announcement nearly two months back.